<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034512446341</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034512446341</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Clinical</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Presence of IL-17<sup>+</sup>/FOXP3<sup>+</sup> Double-positive Cells in Periodontitis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Okui</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512446341">1</xref>
<xref ref-type="aff" rid="aff2-0022034512446341">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Aoki</surname><given-names>Y.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512446341">1</xref>
<xref ref-type="aff" rid="aff2-0022034512446341">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ito</surname><given-names>H.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512446341">1</xref>
<xref ref-type="aff" rid="aff3-0022034512446341">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Honda</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512446341">1</xref>
<xref ref-type="aff" rid="aff3-0022034512446341">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yamazaki</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512446341">1</xref>
<xref ref-type="aff" rid="aff2-0022034512446341">2</xref>
<xref ref-type="corresp" rid="corresp1-0022034512446341">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034512446341"><label>1</label>Center for Transdisciplinary Research, Niigata University, Niigata, Japan</aff>
<aff id="aff2-0022034512446341"><label>2</label>Laboratory of Periodontology and Immunology, Division of Oral Science for Health Promotion, Niigata University Graduate School of Medical and Dental Sciences, 5274 Gakkocho 2-ban-cho, Chuo-ku, Niigata 951-8514, Japan</aff>
<aff id="aff3-0022034512446341"><label>3</label>Division of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan</aff>
<author-notes>
<corresp id="corresp1-0022034512446341"><label>*</label><email>kaz@dent.niigata-u.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>91</volume>
<issue>6</issue>
<fpage>574</fpage>
<lpage>579</lpage>
<history>
<date date-type="received">
<day>4</day>
<month>1</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>3</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>Increasing evidence suggests that distinct inflammatory cytokines convert forkhead box protein P3 (FOXP3<sup>+</sup>) regulatory T-cells (Tregs) into IL-17-producing cells (Th17 cells) <italic>in vitro</italic>. However, this functional plasticity has not been examined in the pathogenesis of periodontal disease. In this study, we analyzed the IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells present in periodontitis lesions to determine the association between Treg conversion and the pathogenesis of periodontitis. The immunohistochemical analysis of gingival tissues demonstrated that the numbers of Th17 cells (IL-17A<sup>+</sup>FOXP3<sup>−</sup>) and Tregs (IL-17A<sup>−</sup>FOXP3<sup>+</sup>) were greater in periodontitis lesions than in gingivitis lesions. We further identified a small number of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells in periodontitis lesions but not in gingivitis lesions. The flow cytometry analysis of CD4<sup>+</sup> T-cell lines established from gingival tissues and the peripheral blood of periodontitis patients showed that the proportion of Tregs was reduced and the proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells among all FOXP3<sup>+</sup> cells was elevated in gingival tissue T-cell lines relative to the proportions in peripheral blood T-cell lines. Our findings indicate that Treg-Th17 conversion may occur in periodontitis lesions. Further studies addressing the role of Treg conversion during inflammatory responses against periodontopathic bacteria are needed.</p>
</abstract>
<kwd-group>
<kwd>CD4<sup>+</sup> lymphocytes</kwd>
<kwd>Th17</kwd>
<kwd>Tregs</kwd>
<kwd>flow cytometry</kwd>
<kwd>immunohistochemistry</kwd>
<kwd>immunology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034512446341" sec-type="intro">
<title>Introduction</title>
<p>Periodontal disease results from an interaction between the host’s defense mechanisms and the micro-organisms present in dental plaque biofilms. Although bacteria play an indispensable role in the initiation of the disease, the progression and severity of the disease are strongly affected by the host immune response. T-cells, especially CD4<sup>+</sup> T helper cells, play an essential role in immune homeostasis, and numerous studies analyzing the role of T-cells in disease have found a disrupted balance between micro-organisms and T-cell responses during disease progression (<xref ref-type="bibr" rid="bibr10-0022034512446341">Gemmell <italic>et al</italic>., 2007</xref>). CD4<sup>+</sup> T helper cells were first classified as T helper 1 (Th1) and T helper 2 (Th2) cells, based on their unique cytokine profiles and biological functions. Th1 cells secrete high levels of IFN-γ and IL-2 and are required for cell-mediated immunity. Th2 cells predominantly secrete IL-4, IL-5, and IL-13 and are required for humoral immunity. Over the past two decades, the pathogenesis of periodontal disease has been exclusively examined in the context of the Th1/Th2 paradigm; however, no consistent results have been obtained (<xref ref-type="bibr" rid="bibr10-0022034512446341">Gemmell <italic>et al</italic>., 2007</xref>). Although these conflicting results may be partly due to differences in the materials and methodologies used, a more complex T-cell response may be responsible for the pathogenesis of periodontal disease.</p>
<p>T helper 17 (Th17) cells are a recently identified CD4<sup>+</sup> T helper subset that preferentially produces IL-17 and is involved in providing host protection against extracellular bacteria and fungi (<xref ref-type="bibr" rid="bibr9-0022034512446341">Gaffen and Hajishengallis, 2008</xref>). In addition, Th17 cells are considered a key T-cell subset involved in the etiology of various autoimmune and inflammatory disorders. In particular, the existence of these cells has resolved underlying discrepancies in the hypothesis regarding the balance of Th1/Th2 responses in experimental autoimmune encephalomyelitis in mice (<xref ref-type="bibr" rid="bibr7-0022034512446341">Cua <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="bibr6-0022034512446341">Chen <italic>et al</italic>., 2006</xref>). We hypothesized that Th17 cells affect the pathogenesis of periodontitis because several groups have reported elevated IL-17 production in periodontitis lesions (<xref ref-type="bibr" rid="bibr14-0022034512446341">Ito <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr12-0022034512446341">Honda <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr5-0022034512446341">Cardoso <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr19-0022034512446341">Ohyama <italic>et al</italic>., 2009</xref>). However, the mechanism through which Th17 cells arise in periodontitis lesions remains largely unknown.</p>
<p>Recently, increasing numbers of groups have reported the conversion of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cells (Tregs) into T-cells with a Th17 phenotype in the presence of appropriate inflammatory cytokines (<xref ref-type="bibr" rid="bibr1-0022034512446341">Afzali <italic>et al</italic>., 2010</xref>). Tregs are characterized by the expression of the lineage-specific transcription factor forkhead box protein P3 (FOXP3) and by active engagement in the maintenance of immunological self-tolerance and immune homeostasis (<xref ref-type="bibr" rid="bibr21-0022034512446341">Sakaguchi, 2004</xref>). Our group and another group have previously demonstrated the presence of increased levels of Treg-related molecules and elevated FOXP3 gene expression in periodontitis lesions (<xref ref-type="bibr" rid="bibr18-0022034512446341">Nakajima <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr4-0022034512446341">Cardoso <italic>et al</italic>., 2008</xref>). However, FOXP3<sup>+</sup> T-cell clones established from periodontitis lesions do not exhibit a suppressive function but act as effector T-cells (<xref ref-type="bibr" rid="bibr20-0022034512446341">Okui <italic>et al</italic>., 2008</xref>). These findings suggest the possibility that a fraction of FOXP3<sup>+</sup> cells in periodontitis lesions may produce IL-17, which promotes inflammatory responses. In this study, we examined the infiltration of IL-17A<sup>+</sup>FOXP3<sup>+</sup> T-cells in periodontitis lesions to determine the association between Treg-Th17 conversion and the pathogenesis of periodontitis.</p>
</sec>
<sec id="section2-0022034512446341" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<sec id="section3-0022034512446341">
<title>Study Population</title>
<p>The experimental protocol used in this study was approved by the Institutional Review Board of the Niigata University Graduate School of Medical and Dental Sciences. Written informed consent was obtained from all patients before their inclusion in the study. For immunohistochemical analysis, gingival tissues from periodontitis lesions (N = 10) were obtained from sites with a probing pocket depth ≥ 5 mm, with bleeding on probing at the time of extraction of teeth due to severe chronic periodontitis. In contrast, gingival tissues from gingivitis lesions (N = 9) were obtained from sites with a probing pocket depth ≤ 3 mm, without bleeding on probing at the time of extraction of teeth for reasons other than periodontitis, <italic>i.e</italic>., severe dental caries or tooth fracture.</p>
<p>To establish CD4<sup>+</sup> T-cell lines, we obtained gingival tissues and peripheral blood from additional patients with chronic periodontitis at the time of periodontal flap surgery (N = 9). All periodontitis tissues were obtained after the initial therapy. The profile of the study population and the clinical parameters at the sites of gingival tissue biopsies are shown in the <xref ref-type="table" rid="table1-0022034512446341">Table</xref>.</p>
<table-wrap id="table1-0022034512446341" position="float">
<label>Table.</label>
<caption>
<p>Study Population and Clinical Parameters at the Sites of Gingival Biopsies</p>
</caption>
<graphic alternate-form-of="table1-0022034512446341" xlink:href="10.1177_0022034512446341-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th align="left">Objectives</th>
<th align="center">Characterization of CD4<sup>+</sup> T-cell Lines from Gingival Tissues and Peripheral Blood</th>
<th align="center" colspan="2">Immunohistochemical Analysis of Gingival Tissues</th>
</tr>
</thead>
<tbody>
<tr>
<td/>
<td/>
<td>Gingivitis</td>
<td>Periodontitis</td>
</tr>
<tr>
<td>Number of patients</td>
<td>9</td>
<td>9</td>
<td>10</td>
</tr>
<tr>
<td>Age (yrs)</td>
<td>54.0 <italic>±</italic> 7.0</td>
<td>54.9 <italic>±</italic> 15.8</td>
<td>64.4 <italic>±</italic> 7.3</td>
</tr>
<tr>
<td>Male/female</td>
<td>5/4</td>
<td>4/5</td>
<td>8/2</td>
</tr>
<tr>
<td>Probing pocket depth</td>
<td>6.3 <italic>±</italic> 1.9</td>
<td>2.3 <italic>±</italic> 0.5</td>
<td>6.9 <italic>±</italic> 2.2<xref ref-type="table-fn" rid="table-fn2-0022034512446341">*</xref></td>
</tr>
<tr>
<td>Clinical attachment level</td>
<td>7.1 <italic>±</italic> 2.4</td>
<td>2.6 <italic>±</italic> 0.7</td>
<td>9.0 <italic>±</italic> 2.5<xref ref-type="table-fn" rid="table-fn2-0022034512446341">*</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0022034512446341">
<p>Age, probing pocket depth, and clinical attachment level are expressed as the mean ± SD.</p>
</fn>
<fn id="table-fn2-0022034512446341">
<label>*</label>
<p>p &lt; 0.0001 <italic>vs</italic>. patients with gingivitis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section4-0022034512446341">
<title>Immunohistochemistry</title>
<p>Serial cryostat sections were prepared from gingival tissue biopsies and subjected to hematoxylin-eosin and immunohistochemical staining. CD3 and CD19, used as markers of T- and B-cells, respectively, were immunohistochemically stained according to a method that we have reported previously (<xref ref-type="bibr" rid="bibr28-0022034512446341">Yamazaki <italic>et al</italic>., 2001</xref>). Double immunofluorescence staining was performed for FOXP3 and IL-17A. Briefly, FOXP3 was stained with a goat polyclonal antibody (Abcam, Cambridge, UK), followed by an Alexa Fluor<sup>®</sup> 488-conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA). IL-17A was stained with a rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), a biotinylated secondary antibody, and a streptavidin-Alexa Fluor<sup>®</sup> 594 conjugate (Invitrogen).</p>
<p>The cells were observed under a Biozero fluorescence microscope (Keyence, Osaka, Japan). Four square areas (1 x 10<sup>5</sup> µm<sup>2</sup> <italic>per</italic> area) were selected from each connective tissue area. The total number of positively stained cells in the four selected areas was counted at 100X magnification. The counts were repeated three times, and minimal variation was observed.</p>
</sec>
<sec id="section5-0022034512446341">
<title>CD4<sup>+</sup> T-cell Lines</title>
<p>CD4<sup>+</sup> T-cell lines were established from gingival tissues (GT T-cell lines) and peripheral blood (PB T-cell lines). Gingival tissues were cut into small pieces in RPMI 1640 containing 10% FCS (JRH Biosciences, Lenexa, KS, USA), 50 U/mL penicillin, 50 µg/mL streptomycin, and 2.5 U/mL dispase and were then filtered through a nylon mesh. The mononuclear cells isolated from gingival tissues or peripheral blood by Ficoll-Paque Plus (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) were enriched with 30 ng/mL anti-CD3 monoclonal antibody (Immunotech, Marseille, France) in the presence of irradiated allogenic peripheral blood mononuclear cells and 50 U/mL recombinant human IL-2 (PeproTech, London, UK). Three wks after stimulation, CD4<sup>+</sup> T-cells were magnetically separated by Human CD4 T Lymphocyte Enrichment Set-DM (BD Biosciences, San Jose, CA, USA). CD4<sup>+</sup> T-cells were then stimulated as described above, cultured for at least 3 wks, and subsequently subjected to CD4<sup>+</sup> magnetic separation to increase the purity to &gt; 95%.</p>
</sec>
<sec id="section6-0022034512446341">
<title>Flow Cytometry</title>
<p>The cytokine production by CD4<sup>+</sup> T-cell lines was assessed by intracellular staining after stimulation with 50 ng/mL phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, St. Louis, MO, USA) and 1 µg/mL ionomycin (Calbiochem, San Diego, CA, USA) for 6 hrs. Monensin was added 2 hrs after the start of the incubation. After the cells were harvested, an anti-human FOXP3 staining set was used to stain cells with an FITC-labeled anti-FOXP3 antibody (clone: PCH101) and a PE-labeled anti-IL-17A antibody (both from eBioscience, San Diego, CA, USA). The expression level of each molecule was analyzed by means of a FACScan flow cytometer and CellQuest Pro software (BD Biosciences).</p>
</sec>
<sec id="section7-0022034512446341">
<title>Statistical Analysis</title>
<p>The unpaired <italic>t</italic> test was used to compare differences in age, probing pocket depth, and clinical attachment level between and among patients. The Mann-Whitney <italic>U</italic>-test was used to compare the number of cells between gingivitis and periodontitis lesions, and the Wilcoxon signed-rank test was used for comparisons between the PB T-cell lines and the GT T-cell lines. The differences were considered significant at p &lt; 0.05. Statistical analyses were performed with GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA, USA).</p>
</sec>
</sec>
<sec id="section8-0022034512446341" sec-type="results">
<title>Results</title>
<sec id="section9-0022034512446341">
<title>Immunohistochemical Identification of IL-17A<sup>+</sup>FOXP3<sup>+</sup> Cells</title>
<p>There was no significant difference between the average age of patients with gingivitis and the average age of patients with periodontitis. The probing pocket depth and clinical attachment level were substantially higher in patients with periodontitis than in patients with gingivitis (<xref ref-type="table" rid="table1-0022034512446341">Table</xref>).</p>
<p>Immunohistochemical analyses demonstrated that a large number of cells expressing CD3, the dominant marker of T-cells, had infiltrated both gingivitis and periodontitis lesions. In contrast, the enhanced infiltration of CD19<sup>+</sup> cells, most of which were B-cells, was observed only in periodontitis lesions (<xref ref-type="fig" rid="fig1-0022034512446341">Figs. 1A</xref>, <xref ref-type="fig" rid="fig1-0022034512446341">1C</xref>). Small numbers of IL-17A<sup>+</sup>FOXP3<sup>−</sup> cells and IL-17A<sup>−</sup> FOXP3<sup>+</sup> cells were identified in periodontitis lesions, whereas these cells were rarely observed in gingivitis lesions. IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells were identified in some periodontitis lesions but not in gingivitis lesions (<xref ref-type="fig" rid="fig1-0022034512446341">Figs. 1B</xref>, <xref ref-type="fig" rid="fig1-0022034512446341">1D</xref>).</p>
<fig id="fig1-0022034512446341" position="float">
<label>Figure 1.</label>
<caption>
<p>Histological images of gingivitis and periodontitis lesions. Serial cryostat sections of gingival tissue biopsies were immunohistochemically double-stained. Representative images of gingivitis lesions (<bold>A, B</bold>) and periodontitis lesions (<bold>C, D</bold>) are shown. (A, C) CD3 and CD19 were labeled with peroxidase (brown) and alkaline phosphatase (blue), respectively. (B, D) IL-17 and FOXP3 were labeled with Alexa Fluor<sup>®</sup> 594 (red) and Alexa Fluor<sup>®</sup> 488 (green), respectively. The arrows indicate IL-17<sup>+</sup>FOXP3<sup>+</sup> double-positive cells (yellow). Scale bars = 50 µm.</p>
</caption>
<graphic xlink:href="10.1177_0022034512446341-fig1.tif"/>
</fig>
<p>Statistical analyses revealed that the number of CD19<sup>+</sup> cells was substantially and significantly higher in periodontitis lesions than in gingivitis lesions (<xref ref-type="fig" rid="fig2-0022034512446341">Fig. 2B</xref>). The number of CD3<sup>+</sup> cells tended to be higher in periodontitis lesions than in gingivitis lesions, but the difference was not significant (<xref ref-type="fig" rid="fig2-0022034512446341">Fig. 2A</xref>). In addition to the numbers of IL-17A<sup>+</sup>FOXP3<sup>−</sup> and IL-17A<sup>−</sup>FOXP3<sup>+</sup> cells, the proportions of IL-17A<sup>+</sup>FOXP3<sup>−</sup> and IL-17A<sup>−</sup>FOXP3<sup>+</sup> cells within the CD3<sup>+</sup> cell subset were significantly higher in periodontitis lesions than in gingivitis lesions (<xref ref-type="fig" rid="fig2-0022034512446341">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034512446341">2D</xref>, 2F, 2G). IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells were identified in 60% of gingival tissues with periodontitis, but not in gingival tissues with gingivitis (<xref ref-type="fig" rid="fig2-0022034512446341">Fig. 2E</xref>). The proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells in the CD3<sup>+</sup> cell subset was less than 2% in periodontitis lesions (<xref ref-type="fig" rid="fig2-0022034512446341">Fig. 2H</xref>).</p>
<fig id="fig2-0022034512446341" position="float">
<label>Figure 2.</label>
<caption>
<p>Immunohistochemical analyses of gingivitis and periodontitis lesions. <bold>(A-E)</bold> The dot plots show the numbers of CD3<sup>+</sup>, CD19<sup>+</sup>, IL-17<sup>+</sup>FOXP3<sup>-</sup>, IL-17-FOXP3<sup>+</sup>, and IL-17<sup>+</sup>FOXP3<sup>+</sup> cells. <bold>(F-H)</bold> The dot plots show the proportions of IL-17<sup>+</sup>FOXP3-, IL-17-FOXP3<sup>+</sup>, and IL-17<sup>+</sup>FOXP3<sup>+</sup> cells within the CD3<sup>+</sup> cell subset. The horizontal lines indicate the medians. ○: Gingivitis lesions. • : Periodontitis lesions. *p &lt; 0.01; **p &lt; 0.001.</p>
</caption>
<graphic xlink:href="10.1177_0022034512446341-fig2.tif"/>
</fig>
</sec>
<sec id="section10-0022034512446341">
<title>Characterization of CD4<sup>+</sup> T-cell Lines</title>
<p>We compared the characteristics of the GT T-cell lines with those of the PB T-cell lines. Because IL-17A and FOXP3 were stained concurrently, we divided the IL-17A<sup>+</sup> and FOXP3<sup>+</sup> cells into 3 groups: IL-17A<sup>+</sup>FOXP3<sup>−</sup>, IL-17A<sup>−</sup>FOXP3<sup>+</sup>, and IL-17A<sup>+</sup> FOXP3<sup>+</sup> cells (<xref ref-type="fig" rid="fig3-0022034512446341">Fig. 3A</xref>). The proportion of IL-17A<sup>+</sup>FOXP3<sup>−</sup> and IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells tended to be higher in GT T-cell lines than in PB T-cell lines; however, no significant differences were observed (<xref ref-type="fig" rid="fig3-0022034512446341">Figs. 3B</xref>, <xref ref-type="fig" rid="fig3-0022034512446341">3D</xref>). In contrast, the proportion of IL-17A<sup>−</sup>FOXP3<sup>+</sup> cells was significantly lower in GT T-cell lines than in PB T-cell lines (<xref ref-type="fig" rid="fig3-0022034512446341">Fig. 3C</xref>). Because we assumed that IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells could be derived from FOXP3 single-positive cells as a result of conversion, we analyzed the proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells within the total FOXP3<sup>+</sup> cell subset. This analysis revealed that the proportion of these double-positive cells was significantly higher in GT T-cell lines than in PB T-cell lines (<xref ref-type="fig" rid="fig3-0022034512446341">Fig. 3E</xref>).</p>
<fig id="fig3-0022034512446341" position="float">
<label>Figure 3.</label>
<caption>
<p>The characteristics of PB T-cell lines and GT T-cell lines. After the cells were stimulated with PMA and ionomycin, we performed intracellular staining to analyze the cells with flow cytometry. <bold>(A)</bold> Representative dot plots for the double-staining of IL-17A and FOXP3. <bold>(B-D)</bold> The dot plots show the proportions of IL-17A<sup>+</sup>FOXP3<sup>-</sup>, IL-17A<sup>-</sup>FOXP3<sup>+</sup>, and IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells in the T-cell lines. <bold>(E)</bold> The dot plots show the proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells within the total FOXP3<sup>+</sup> cell subset. The horizontal lines indicate the medians. ○: PB T-cell lines. • : GT T-cell lines. *p &lt; 0.05.</p>
</caption>
<graphic xlink:href="10.1177_0022034512446341-fig3.tif"/>
</fig>
</sec>
</sec>
<sec id="section11-0022034512446341" sec-type="discussion">
<title>Discussion</title>
<p>Immunohistochemical analyses showed that Th17 cell infiltration increased in periodontitis lesions, a result that is consistent with several reports showing elevated IL-17 mRNA and protein levels in gingival tissues from periodontitis lesions compared with healthy sites (<xref ref-type="bibr" rid="bibr16-0022034512446341">Lester <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr12-0022034512446341">Honda <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr5-0022034512446341">Cardoso <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr19-0022034512446341">Ohyama <italic>et al</italic>., 2009</xref>). The question of whether an increase in the number of Th17 cells in periodontitis lesions is beneficial or harmful has attracted much attention. IL-17RA-deficient mice show severe <italic>Porphyromonas gingivalis-</italic>induced periodontal bone destruction, due to deficits in neutrophil migration, expansion, and recruitment (<xref ref-type="bibr" rid="bibr29-0022034512446341">Yu <italic>et al</italic>., 2007</xref>). Although this mouse model primarily develops the acute phase of periodontitis, an appropriate amount of IL-17 is likely crucial for protection against periodontopathic bacteria. However, uncontrolled IL-17 production may cause bone destruction, as has been observed in patients with rheumatoid arthritis (<xref ref-type="bibr" rid="bibr22-0022034512446341">Sato <italic>et al</italic>., 2006</xref>). Therefore, the precise role of Th17 cells in periodontitis is yet to be elucidated in humans.</p>
<p>Immunosuppressive mechanisms also play a crucial role in the pathogenesis of periodontitis. In the present study, although some non-regulatory CD4<sup>+</sup> T-cells transiently expressed FOXP3 following stimulation <italic>in vitro</italic> (<xref ref-type="bibr" rid="bibr26-0022034512446341">Wang <italic>et al</italic>., 2007</xref>), the number of FOXP3<sup>+</sup> cells was lower in GT T-cell lines than in PB T-cell lines. In addition, the level of Treg infiltration was greater in periodontitis lesions, consistent with our previous report (<xref ref-type="bibr" rid="bibr18-0022034512446341">Nakajima <italic>et al</italic>., 2005</xref>). Although there may be a lower rate of Treg migration than effector CD4<sup>+</sup> T-cell migration into periodontitis lesions, Tregs may accumulate in the lesions to control inflammation.</p>
<p>It is possible that a fraction of FOXP3<sup>+</sup> cells in periodontitis lesions are functionally different from conventional Tregs. Tregs and Th17 cells arise from common precursors in a reciprocal manner based on exposure to TGF-β alone or TGF-β plus IL-6, respectively (<xref ref-type="bibr" rid="bibr1-0022034512446341">Afzali <italic>et al</italic>., 2010</xref>). Alternatively, recent studies have shown that appropriate stimuli can convert Tregs into Th17 cells in humans. Tregs stimulated with antigen-presenting cells or T-cell-activating beads differentiated into IL-17-producing cells in the presence of IL-2, and this differentiation was further enhanced by IL-1β, IL-21, and IL-23 (<xref ref-type="bibr" rid="bibr15-0022034512446341">Koenen <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr8-0022034512446341">Deknuydt <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr24-0022034512446341">Valmori <italic>et al</italic>., 2010</xref>). The cytokines involved in Treg-Th17 conversion have been reported to be more abundant in periodontitis sites than in clinically healthy sites (<xref ref-type="bibr" rid="bibr11-0022034512446341">Honda <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr16-0022034512446341">Lester <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr5-0022034512446341">Cardoso <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr19-0022034512446341">Ohyama <italic>et al</italic>., 2009</xref>). Although the concentration of IL-2 appears to be lower relative to the levels of other cytokines, the numbers of mRNA-expressing and protein-producing cells are also higher in periodontitis lesions than in gingivitis lesions (<xref ref-type="bibr" rid="bibr27-0022034512446341">Yamazaki <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="bibr23-0022034512446341">Tokoro <italic>et al</italic>., 1997</xref>). Thus, periodontitis lesions may provide a suitable environment for inducing this conversion.</p>
<p>Treg-derived IL-17-producing cells initially develop into IL-17A<sup>+</sup>FOXP3<sup>+</sup> double-positive cells and retain suppressive function; however, a fraction of these cells gradually lose FOXP3 expression and become non-suppressive IL-17 single-positive cells (<xref ref-type="bibr" rid="bibr15-0022034512446341">Koenen <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr2-0022034512446341">Beriou <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr8-0022034512446341">Deknuydt <italic>et al</italic>., 2009</xref>). These changes have been examined in the context of various physiological and pathological settings. The proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells within the total FOXP3<sup>+</sup> cell subset was much higher in tonsils than in peripheral blood under physiological conditions (<xref ref-type="bibr" rid="bibr25-0022034512446341">Voo <italic>et al</italic>., 2009</xref>). Increased numbers of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells were found in areas of active psoriasis (<xref ref-type="bibr" rid="bibr3-0022034512446341">Bovenschen <italic>et al</italic>., 2011</xref>), in patients with allergic rhinitis and nasal polyposis (<xref ref-type="bibr" rid="bibr17-0022034512446341">Liu <italic>et al</italic>., 2011</xref>), and in patients with Crohn’s disease (<xref ref-type="bibr" rid="bibr13-0022034512446341">Hovhannisyan <italic>et al</italic>., 2011</xref>), suggesting an association between Treg-Th17 conversion and various inflammatory disorders.</p>
<p>In this study, we first showed that IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells were present only in periodontitis lesions, and that the proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells was variable from patient to patient. Furthermore, the proportion of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells within the total FOXP3<sup>+</sup> cell subset was also elevated in GT T-cell lines compared with PB T-cell lines. As with the immunohistological findings, the proportion of the IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells was variable among T-cell lines. This could be due to differences in the local inflammatory conditions of the sampling sites, although clinical parameters were similar. However, there is a limitation in this study: Analyzed tissues may not truly reflect the status of untreated tissues, because the tissues were obtained after initial therapy that could modify or reduce the inflammatory response.</p>
<p>The reasons for the elevated proportion of double-positive cells are considered as follows: (1) IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells are recruited from the circulation into periodontitis lesions, and (2) IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells are generated through Treg-Th17 conversion in periodontitis lesions. Although no studies have demonstrated the homing of IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells to inflammatory tissues, this hypothesis cannot be excluded entirely, because a few IL-17A<sup>+</sup>FOXP3<sup>+</sup> cells were identified in the PB T-cell line. The latter possibility is more likely, because the cytokines required for conversion have been reported to be abundant in periodontitis lesions, as described earlier. However, it was difficult to estimate the proportion of Tregs that had converted into Th17 cells in periodontitis lesions, because no method currently exists for distinguishing Treg-derived IL-17 single-positive cells from original Th17 cells. Further studies addressing the precise role of Treg-Th17 conversion in inflammatory responses against periodontopathic bacteria are needed to understand the pathogenesis of periodontitis.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supported-by">
<p>This work was supported by Grants-in-Aid for Scientific Research from the <grant-sponsor>Japanese Society for the Promotion of Science</grant-sponsor> (<grant-num>20659325</grant-num>, <grant-num>21792116</grant-num>, <grant-num>23390476</grant-num>, and <grant-num>23659974</grant-num>), <grant-sponsor>the Young Researcher Overseas Visits Program</grant-sponsor> for Vitalizing Brain Circulation (<grant-num>S2203</grant-num>), and the Promotion of Niigata University Research Project.</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Afzali</surname><given-names>B</given-names></name>
<name><surname>Mitchell</surname><given-names>P</given-names></name>
<name><surname>Lechler</surname><given-names>RI</given-names></name>
<name><surname>John</surname><given-names>S</given-names></name>
<name><surname>Lombardi</surname><given-names>G</given-names></name>
</person-group> (<year>2010</year>). <article-title>Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T-cells</article-title>. <source>Clin Exp Immunol</source> <volume>159</volume>:<fpage>120</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr2-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beriou</surname><given-names>G</given-names></name>
<name><surname>Costantino</surname><given-names>CM</given-names></name>
<name><surname>Ashley</surname><given-names>CW</given-names></name>
<name><surname>Yang</surname><given-names>L</given-names></name>
<name><surname>Kuchroo</surname><given-names>VK</given-names></name>
<name><surname>Baecher-Allan</surname><given-names>C</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>IL-17-producing human peripheral regulatory T-cells retain suppressive function</article-title>. <source>Blood</source> <volume>113</volume>:<fpage>4240</fpage>-<lpage>4249</lpage>.</citation>
</ref>
<ref id="bibr3-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bovenschen</surname><given-names>HJ</given-names></name>
<name><surname>van de Kerkhof</surname><given-names>PC</given-names></name>
<name><surname>van Erp</surname><given-names>PE</given-names></name>
<name><surname>Woestenenk</surname><given-names>R</given-names></name>
<name><surname>Joosten</surname><given-names>I</given-names></name>
<name><surname>Koenen</surname><given-names>HJ</given-names></name>
</person-group> (<year>2011</year>). <article-title>Foxp3<sup>+</sup> regulatory T-cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin</article-title>. <source>J Invest Dermatol</source> <volume>131</volume>:<fpage>1853</fpage>-<lpage>1860</lpage>.</citation>
</ref>
<ref id="bibr4-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cardoso</surname><given-names>CR</given-names></name>
<name><surname>Garlet</surname><given-names>GP</given-names></name>
<name><surname>Moreira</surname><given-names>AP</given-names></name>
<name><surname>Junior</surname><given-names>WM</given-names></name>
<name><surname>Rossi</surname><given-names>MA</given-names></name>
<name><surname>Silva</surname><given-names>JS</given-names></name>
</person-group> (<year>2008</year>). <article-title>Characterization of CD4<sup>+</sup>CD25<sup>+</sup> natural regulatory T-cells in the inflammatory infiltrate of human chronic periodontitis</article-title>. <source>J Leukoc Biol</source> <volume>84</volume>:<fpage>311</fpage>-<lpage>318</lpage>.</citation>
</ref>
<ref id="bibr5-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cardoso</surname><given-names>CR</given-names></name>
<name><surname>Garlet</surname><given-names>GP</given-names></name>
<name><surname>Crippa</surname><given-names>GE</given-names></name>
<name><surname>Rosa</surname><given-names>AL</given-names></name>
<name><surname>Junior</surname><given-names>WM</given-names></name>
<name><surname>Rossi</surname><given-names>MA</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease</article-title>. <source>Oral Microbiol Immunol</source> <volume>24</volume>:<fpage>1</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr6-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y</given-names></name>
<name><surname>Langrish</surname><given-names>CL</given-names></name>
<name><surname>McKenzie</surname><given-names>B</given-names></name>
<name><surname>Joyce-Shaikh</surname><given-names>B</given-names></name>
<name><surname>Stumhofer</surname><given-names>JS</given-names></name>
<name><surname>McClanahan</surname><given-names>T</given-names></name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis</article-title>. <source>J Clin Invest</source> <volume>116</volume>:<fpage>1317</fpage>-<lpage>1326</lpage>.</citation>
</ref>
<ref id="bibr7-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cua</surname><given-names>DJ</given-names></name>
<name><surname>Sherlock</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>Y</given-names></name>
<name><surname>Murphy</surname><given-names>CA</given-names></name>
<name><surname>Joyce</surname><given-names>B</given-names></name>
<name><surname>Seymour</surname><given-names>B</given-names></name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain</article-title>. <source>Nature</source> <volume>421</volume>:<fpage>744</fpage>-<lpage>748</lpage>.</citation>
</ref>
<ref id="bibr8-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deknuydt</surname><given-names>F</given-names></name>
<name><surname>Bioley</surname><given-names>G</given-names></name>
<name><surname>Valmori</surname><given-names>D</given-names></name>
<name><surname>Ayyoub</surname><given-names>M</given-names></name>
</person-group> (<year>2009</year>). <article-title>IL-1β and IL-2 convert human Treg into T<sub>H</sub>17 cells</article-title>. <source>Clin Immunol</source> <volume>131</volume>:<fpage>298</fpage>-<lpage>307</lpage>.</citation>
</ref>
<ref id="bibr9-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaffen</surname><given-names>SL</given-names></name>
<name><surname>Hajishengallis</surname><given-names>G</given-names></name>
</person-group> (<year>2008</year>). <article-title>A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17</article-title>. <source>J Dent Res</source> <volume>87</volume>:<fpage>817</fpage>-<lpage>828</lpage>.</citation>
</ref>
<ref id="bibr10-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gemmell</surname><given-names>E</given-names></name>
<name><surname>Yamazaki</surname><given-names>K</given-names></name>
<name><surname>Seymour</surname><given-names>GJ</given-names></name>
</person-group> (<year>2007</year>). <article-title>The role of T-cells in periodontal disease: homeostasis and autoimmunity</article-title>. <source>Periodontol 2000</source> <volume>43</volume>:<fpage>14</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr11-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Honda</surname><given-names>T</given-names></name>
<name><surname>Domon</surname><given-names>H</given-names></name>
<name><surname>Okui</surname><given-names>T</given-names></name>
<name><surname>Kajita</surname><given-names>K</given-names></name>
<name><surname>Amanuma</surname><given-names>R</given-names></name>
<name><surname>Yamazaki</surname><given-names>K</given-names></name>
</person-group> (<year>2006</year>). <article-title>Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions</article-title>. <source>Clin Exp Immunol</source> <volume>144</volume>:<fpage>35</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr12-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Honda</surname><given-names>T</given-names></name>
<name><surname>Aoki</surname><given-names>Y</given-names></name>
<name><surname>Takahashi</surname><given-names>N</given-names></name>
<name><surname>Maekawa</surname><given-names>T</given-names></name>
<name><surname>Nakajima</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>H</given-names></name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease</article-title>. <source>Clin Chim Acta</source> <volume>395</volume>:<fpage>137</fpage>-<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr13-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hovhannisyan</surname><given-names>Z</given-names></name>
<name><surname>Treatman</surname><given-names>J</given-names></name>
<name><surname>Littman</surname><given-names>DR</given-names></name>
<name><surname>Mayer</surname><given-names>L</given-names></name>
</person-group> (<year>2011</year>). <article-title>Characterization of interleukin-17-producing regulatory T-cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases</article-title>. <source>Gastroenterology</source> <volume>140</volume>:<fpage>957</fpage>-<lpage>965</lpage>.</citation>
</ref>
<ref id="bibr14-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ito</surname><given-names>H</given-names></name>
<name><surname>Honda</surname><given-names>T</given-names></name>
<name><surname>Domon</surname><given-names>H</given-names></name>
<name><surname>Oda</surname><given-names>T</given-names></name>
<name><surname>Okui</surname><given-names>T</given-names></name>
<name><surname>Amanuma</surname><given-names>R</given-names></name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Gene expression analysis of the CD4<sup>+</sup> T-cell clones derived from gingival tissues of periodontitis patients</article-title>. <source>Oral Microbiol Immunol</source> <volume>20</volume>:<fpage>382</fpage>-<lpage>386</lpage>.</citation>
</ref>
<ref id="bibr15-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koenen</surname><given-names>HJ</given-names></name>
<name><surname>Smeets</surname><given-names>RL</given-names></name>
<name><surname>Vink</surname><given-names>PM</given-names></name>
<name><surname>van Rijssen</surname><given-names>E</given-names></name>
<name><surname>Boots</surname><given-names>AM</given-names></name>
<name><surname>Joosten</surname><given-names>I</given-names></name>
</person-group> (<year>2008</year>). <article-title>Human CD25<sup>high</sup>Foxp3<sup>pos</sup> regulatory T-cells differentiate into IL-17-producing cells</article-title>. <source>Blood</source> <volume>112</volume>:<fpage>2340</fpage>-<lpage>2352</lpage>.</citation>
</ref>
<ref id="bibr16-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lester</surname><given-names>SR</given-names></name>
<name><surname>Bain</surname><given-names>JL</given-names></name>
<name><surname>Johnson</surname><given-names>RB</given-names></name>
<name><surname>Serio</surname><given-names>FG</given-names></name>
</person-group> (<year>2007</year>). <article-title>Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss</article-title>. <source>J Periodontol</source> <volume>78</volume>:<fpage>1545</fpage>-<lpage>1550</lpage>.</citation>
</ref>
<ref id="bibr17-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>T</given-names></name>
<name><surname>Song</surname><given-names>CH</given-names></name>
<name><surname>Liu</surname><given-names>AM</given-names></name>
<name><surname>Xie</surname><given-names>C</given-names></name>
<name><surname>Zhao</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Forkhead box P3<sup>+</sup> T-cells express interleukin-17 in nasal mucosa of patients with both allergic rhinitis and polyposis</article-title>. <source>Clin Exp Immunol</source> <volume>163</volume>:<fpage>59</fpage>-<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr18-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakajima</surname><given-names>T</given-names></name>
<name><surname>Ueki-Maruyama</surname><given-names>K</given-names></name>
<name><surname>Oda</surname><given-names>T</given-names></name>
<name><surname>Ohsawa</surname><given-names>Y</given-names></name>
<name><surname>Ito</surname><given-names>H</given-names></name>
<name><surname>Seymour</surname><given-names>GJ</given-names></name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Regulatory T-cells infiltrate periodontal disease tissues</article-title>. <source>J Dent Res</source> <volume>84</volume>:<fpage>639</fpage>-<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr19-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohyama</surname><given-names>H</given-names></name>
<name><surname>Kato-Kogoe</surname><given-names>N</given-names></name>
<name><surname>Kuhara</surname><given-names>A</given-names></name>
<name><surname>Nishimura</surname><given-names>F</given-names></name>
<name><surname>Nakasho</surname><given-names>K</given-names></name>
<name><surname>Yamanegi</surname><given-names>K</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>The involvement of IL-23 and the Th17 pathway in periodontitis</article-title>. <source>J Dent Res</source> <volume>88</volume>:<fpage>633</fpage>-<lpage>638</lpage>.</citation>
</ref>
<ref id="bibr20-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okui</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>H</given-names></name>
<name><surname>Honda</surname><given-names>T</given-names></name>
<name><surname>Amanuma</surname><given-names>R</given-names></name>
<name><surname>Yoshie</surname><given-names>H</given-names></name>
<name><surname>Yamazaki</surname><given-names>K</given-names></name>
</person-group> (<year>2008</year>). <article-title>Characterization of CD4<sup>+</sup> FOXP3<sup>+</sup> T-cell clones established from chronic inflammatory lesions</article-title>. <source>Oral Microbiol Immunol</source> <volume>23</volume>: <fpage>49</fpage>-<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr21-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sakaguchi</surname><given-names>S</given-names></name>
</person-group> (<year>2004</year>). <article-title>Naturally arising CD4<sup>+</sup> regulatory T-cells for immunologic self-tolerance and negative control of immune responses</article-title>. <source>Annu Rev Immunol</source> <volume>22</volume>:<fpage>531</fpage>-<lpage>562</lpage>.</citation>
</ref>
<ref id="bibr22-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sato</surname><given-names>K</given-names></name>
<name><surname>Suematsu</surname><given-names>A</given-names></name>
<name><surname>Okamoto</surname><given-names>K</given-names></name>
<name><surname>Yamaguchi</surname><given-names>A</given-names></name>
<name><surname>Morishita</surname><given-names>Y</given-names></name>
<name><surname>Kadono</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Th17 functions as an osteoclastogenic helper T-cell subset that links T-cell activation and bone destruction</article-title>. <source>J Exp Med</source> <volume>203</volume>: <fpage>2673</fpage>-<lpage>2682</lpage>.</citation>
</ref>
<ref id="bibr23-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tokoro</surname><given-names>Y</given-names></name>
<name><surname>Matsuki</surname><given-names>Y</given-names></name>
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
<name><surname>Suzuki</surname><given-names>T</given-names></name>
<name><surname>Hara</surname><given-names>K</given-names></name>
</person-group> (<year>1997</year>). <article-title>Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases</article-title>. <source>Clin Exp Immunol</source> <volume>107</volume>:<fpage>166</fpage>-<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr24-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Valmori</surname><given-names>D</given-names></name>
<name><surname>Raffin</surname><given-names>C</given-names></name>
<name><surname>Raimbaud</surname><given-names>I</given-names></name>
<name><surname>Ayyoub</surname><given-names>M</given-names></name>
</person-group> (<year>2010</year>). <article-title>Human RORγt<sup>+</sup> T<sub>H</sub>17 cells preferentially differentiate from naive FOXP3<sup>+</sup> Treg in the presence of lineage-specific polarizing factors</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>107</volume>:<fpage>19402</fpage>-<lpage>19407</lpage>.</citation>
</ref>
<ref id="bibr25-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Voo</surname><given-names>KS</given-names></name>
<name><surname>Wang</surname><given-names>YH</given-names></name>
<name><surname>Santori</surname><given-names>FR</given-names></name>
<name><surname>Boggiano</surname><given-names>C</given-names></name>
<name><surname>Arima</surname><given-names>K</given-names></name>
<name><surname>Bover</surname><given-names>L</given-names></name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Identification of IL-17-producing FOXP3<sup>+</sup> regulatory T-cells in humans</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>106</volume>:<fpage>4793</fpage>-<lpage>4798</lpage>.</citation>
</ref>
<ref id="bibr26-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Ioan-Facsinay</surname><given-names>A</given-names></name>
<name><surname>van der Voort</surname><given-names>EI</given-names></name>
<name><surname>Huizinga</surname><given-names>TW</given-names></name>
<name><surname>Toes</surname><given-names>RE</given-names></name>
</person-group> (<year>2007</year>). <article-title>Transient expression of FOXP3 in human activated nonregulatory CD4<sup>+</sup> T-cells</article-title>. <source>Eur J Immunol</source> <volume>37</volume>:<fpage>129</fpage>-<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr27-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamazaki</surname><given-names>K</given-names></name>
<name><surname>Nakajima</surname><given-names>T</given-names></name>
<name><surname>Hara</surname><given-names>K</given-names></name>
</person-group> (<year>1995</year>). <article-title>Immunohistological analysis of T-cell functional subsets in chronic inflammatory periodontal disease</article-title>. <source>Clin Exp Immunol</source> <volume>99</volume>:<fpage>384</fpage>-<lpage>391</lpage>.</citation>
</ref>
<ref id="bibr28-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamazaki</surname><given-names>K</given-names></name>
<name><surname>Ohsawa</surname><given-names>Y</given-names></name>
<name><surname>Yoshie</surname><given-names>H</given-names></name>
</person-group> (<year>2001</year>). <article-title>Elevated proportion of natural killer T-cells in periodontitis lesions: a common feature of chronic inflammatory diseases</article-title>. <source>Am J Pathol</source> <volume>158</volume>:<fpage>1391</fpage>-<lpage>1398</lpage>.</citation>
</ref>
<ref id="bibr29-0022034512446341">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>JJ</given-names></name>
<name><surname>Ruddy</surname><given-names>MJ</given-names></name>
<name><surname>Wong</surname><given-names>GC</given-names></name>
<name><surname>Sfintescu</surname><given-names>C</given-names></name>
<name><surname>Baker</surname><given-names>PJ</given-names></name>
<name><surname>Smith</surname><given-names>JB</given-names></name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals</article-title>. <source>Blood</source> <volume>109</volume>:<fpage>3794</fpage>-<lpage>3802</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>